Comparative multicenter analysis of sleeve gastrectomy, gastric bypass, and duodenal switch in patients with BMI ≥70kg/m 2 : a 2-year follow-up.
| Autor: | Abi Mosleh K; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Lind R; Weight Loss and Bariatric Surgery Institute, Orlando Health, Orlando, Florida, USA., Salame M; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Jawad MA; Weight Loss and Bariatric Surgery Institute, Orlando Health, Orlando, Florida, USA., Ghanem M; Weight Loss and Bariatric Surgery Institute, Orlando Health, Orlando, Florida, USA., Hage K; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Abu Dayyeh BK; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Kendrick M; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Teixeira AF; Weight Loss and Bariatric Surgery Institute, Orlando Health, Orlando, Florida, USA., Ghanem OM; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: ghanem.omar@mayo.edu. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery [Surg Obes Relat Dis] 2024 Apr; Vol. 20 (4), pp. 399-405. Date of Electronic Publication: 2023 Nov 30. |
| DOI: | 10.1016/j.soard.2023.11.011 |
| Abstrakt: | Patients undergoing metabolic and bariatric surgery (MBS) with body mass index (BMI) ≥ 70 kg/m 2 are considered a high-risk group. There is limited literature to guide surgeons on the perioperative safety as well as the different procedural outcomes of MBS in this cohort. Our aim is to compare the safety profiles, early- and medium-term outcomes of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and duodenal switch (DS) in patients with BMI ≥ 70 kg/m 2 . A total of 156 patients with BMI ≥ 70kg/m 2 underwent MBS (SG = 40, RYGB = 40, and DS = 76). Mean baseline BMI was 75.5 kg/m 2 . Total weight loss (%TWL) at 24 months was highest in the DS group compared to RYGB (40.6% versus 33.8%, P value = .03) and SG (40.6% versus 28.5%, P value = .006). There was no significant difference in %TWL between RYGB and SG (33.8% versus 28.5%, P value = .20). The 30-day complication rates were similar [SG (7.5%), RYGB (10%), and DS (9.2%) (P value = 1.0)]. There was one reported leak (DS). The 30-day mortality was zero. MBS is safe and effective in patients with BMI ≥ 70 kg/m 2 . All procedures had comparable safety profiles and complication rates. While DS achieved the highest %TWL at 24 months, similar comorbidity resolution rates among the procedures attenuate its clinical significance. (Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|